Clinical Trial Update: A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lobaplatin/etoposide with or without anlotinib maintenance in extensive-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Lobaplatin/etoposide with or without anlotinib maintenance

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN